Cargando…

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up

Detalles Bibliográficos
Autores principales:	Alpigiani, MG, Salvati, P, Callegari, S, Bagnis, A, Papadia, M, Traverso, CE, Lorini, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194545/ http://dx.doi.org/10.1186/1546-0096-9-S1-P189

Ejemplares similares

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA)
por: Alpigiani, Maria Giannina, et al.
Publicado: (2014)

PReS-FINAL-2092: Bone marrow cells (BMC) added to platelet-rich plasma (PRP) for treatment of bone degenerative processes in JIA patients: follow-up of 2 cases
por: Salvati, P, et al.
Publicado: (2013)

Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report
por: Alpigiani, MG, et al.
Publicado: (2011)

Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders
por: Alpigiani, MG, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
por: Ramanan, Athimalaipet V., et al.
Publicado: (2018)

Abatacept in the treatment of polyarticular JIA: development, clinical utility, and place in therapy
por: Goldzweig, Ofra, et al.
Publicado: (2011)

TNF-alfa blockers- promising therapy for chronic uveitis in very young children
por: Tauber, T, et al.
Publicado: (2008)

Histone antibodies as a biomarker of uveitis in JIA
por: Nordal, Ellen B, et al.
Publicado: (2014)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease
por: Park, Ji-Youn, et al.
Publicado: (2015)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

KIR-HLA class I combinations in JIA-associated uveitis
por: Parsa, Miriam, et al.
Publicado: (2012)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Psychological Effects and Quality of Life in Parents and Children with Jia-Associated Uveitis
por: Guerriero, Silvana, et al.
Publicado: (2022)

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2019)

Tocilizumab and Abatacept for the Treatment of Childhood Chronic Uveitis: A Monocentric Comparison Experience
por: Maccora, Ilaria, et al.
Publicado: (2022)

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2020)

PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA)
por: Miranda, V, et al.
Publicado: (2013)

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
por: Joos, R, et al.
Publicado: (2011)

Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
por: Angeles-Han, Sheila T., et al.
Publicado: (2015)

Clinical benefits and potential risks of adalimumab in non‐JIA chronic paediatric uveitis
por: Kouwenberg, Carlyn V., et al.
Publicado: (2021)

An Unusual Retinal Vessel Modification in Patients Affected by JIA-Uveitis with a Follow-Up Longer Than 16 Years
por: Abbouda, Alessandro, et al.
Publicado: (2020)

Acute onset anterior uveitis after darbepoetin alfa infusion
por: Li, Jonathan, et al.
Publicado: (2015)

Understanding the biology and use of TNF therapy in jia-clinical outcomes
por: Lovell, Daniel, et al.
Publicado: (2014)

The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
por: Davies, Rebecca, et al.
Publicado: (2020)

Long Term Experience in Patients With JIA-Associated Uveitis in a Large Referral Center
por: Marelli, Luca, et al.
Publicado: (2021)

A Case of Refractory Polymyositis Successfully Treated With Abatacept Monotherapy
por: ÇAĞLAYAN, Mehmet, et al.
Publicado: (2020)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
por: Salmaso, A, et al.
Publicado: (2008)

Encouraging visual outcomes in children with idiopathic and JIA associated uveitis: a population-based study
por: Siiskonen, Mira, et al.
Publicado: (2023)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Understanding the biology and use of anti-TNF agents in JIA – interim results
por: Lovell, Daniel J, et al.
Publicado: (2012)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Lundquist, Lisa M, et al.
Publicado: (2012)

Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency
por: Boz, Valentina, et al.
Publicado: (2021)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Short-term efficacy of abatacept in the treatment of refractory ocular and cutaneous Behçet’s disease
por: Maciel, Marcus de Luca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_alojrmlglg4i9so7gdtj2oao67